If you need more lookups,
subscriptions start at $34 USD/month.
Mark Vaeck Location
Ghent, BE
Mark Vaeck Work
Chairman of the Board @ myNEO Therapeutics NV (June 2021 - Present)
CEO @ (May 2010 - Present)
Board member @ InteRNA (January 2011 - January 2019)
CEO @ ActoGeniX N.V. (June 2006 - May 2010)
CEO @ Ablynx NV (January 2001 - January 2006)
Mark Vaeck Education
Vrije Universiteit Brussel 1977-1982
Mark Vaeck Skills
Antibodies
Biochemistry
Biomarker Discovery
Biopharmaceuticals
Biotechnology
Cell
Clinical Development
Drug Development
Drug Discovery
Genetics
Genomics
Immunology
Infectious Diseases
Life Sciences
Lifesciences
Management
Microbiology
Molecular Biology
Oncology
Pharmaceutical Industry
Protein Chemistry
Strategy
Technology Transfer
Vaccines
Venture Capital
Microsoft Office
Leadership
Microsoft Word
Program Management
Training
Research
Process Improvement
Social Media
Business Strategy
Project Management
Mark Vaeck Summary
Mark Vaeck, based in Ghent, BE, is currently a CEO at Complix N.V.. Mark Vaeck brings experience from previous roles at myNEO Therapeutics NV, InteRNA, ActoGeniX N.V. and Ablynx NV. Mark Vaeck holds a 1977 - 1982 Vrije Universiteit Brussel. With a robust skill set that includes Antibodies, Biochemistry, Biomarker Discovery, Biopharmaceuticals, Biotechnology and more. Mark Vaeck has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Vaeck?
Find contact details for 700 million professionals.